Hee Chul Park

Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial

Yong Sang Hong, Byung‐Ho Nam, Kyu-pyo Kim et al. · The Lancet Oncology · 2014 · 384 citations

Medicine, Oncology, Surgery +17

Dose-response relationship in local radiotherapy for hepatocellular carcinoma

Hee Chul Park, Jinsil Seong, Kwang‐Hyub Han et al. · International Journal of Radiation Oncology*Biology*Physics · 2002 · 305 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients

Jinsil Seong, Hee Chul Park, Kwang‐Hyub Han et al. · International Journal of Radiation Oncology*Biology*Physics · 2003 · 167 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial

Yong Sang Hong, Sun Young Kim, Ji Sung Lee et al. · Journal of Clinical Oncology · 2019 · 167 citations

Medicine, Oncology, Surgery +17

Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial

Jung Yong Hong, Hee Jin Cho, K. Jason et al. · Genome Medicine · 2022 · 136 citations · Full text

Medicine, Immunology, Oncology +17